How reforms to the Patented Medicines Price Review Board will impact the pharmaceutical industry in Canada

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/f8/37/83/f8378352-9526-b070-a29a-98d9db3ba34b/mza_6979930184885470897.jpg/600x600bb.jpg

McGill Journal of Law and Health Podcast

McGill Journal of Law and Health

26 episodes

1 week ago

The McGill Journal of Law and Health (MJLH) / Revue de droit et santé de McGill (RDSM) is a bilingual peer-reviewed academic journal based at the Faculty of Law of McGill University. The MJLH/RDSM Podcast aims to share informative and interesting episodes about current issues of law and policy relating to health. If you have any comments or questions about the MJLH/RDSM podcast, please email info.mjlh@mcgill.ca.

Education

RSS

All content for McGill Journal of Law and Health Podcast is the property of McGill Journal of Law and Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Education

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/7898435/7898435-1596665284802-e957aeeb9ef4.jpg

How reforms to the Patented Medicines Price Review Board will impact the pharmaceutical industry in Canada

McGill Journal of Law and Health Podcast

42 minutes 59 seconds

2 years ago

How reforms to the Patented Medicines Price Review Board will impact the pharmaceutical industry in Canada

In this episode of the McGill Journal of Law and Health Podcast Series, Hailey Laxer invites guests Me Miriam Clouthier, associate at IMK and Chris Macleod, lawyer at Cambridge LLP and Chair of the Canadian Cystic Fibrosis Treatment Society, to discuss the PMPRB – the Patented Medicine Prices Review Board – and how the recent proposed reforms to the PMPRB affect the pharmaceutical industry in Canada and access to medications, particularly, concerning innovative therapies for Canadian patients.